Published in Neurology on August 09, 2013
Prevalence of mixed pathologies in the aging brain. Alzheimers Res Ther (2014) 1.11
Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence. Neurobiol Aging (2014) 1.08
Contemplating Alzheimer's disease and the contribution of white matter hyperintensities. Curr Neurol Neurosci Rep (2013) 1.02
Diabetes, markers of brain pathology and cognitive function: the Age, Gene/Environment Susceptibility-Reykjavik Study. Ann Neurol (2014) 1.01
Post-mortem assessment in vascular dementia: advances and aspirations. BMC Med (2016) 0.98
Antemortem MRI findings associated with microinfarcts at autopsy. Neurology (2014) 0.93
Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures. Neuroimage Clin (2015) 0.92
Challenges of multimorbidity of the aging brain: a critical update. J Neural Transm (Vienna) (2014) 0.92
The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease. J Alzheimers Dis (2015) 0.90
Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals. J Cereb Blood Flow Metab (2016) 0.88
Clinical and imaging features of mixed Alzheimer and vascular pathologies. Alzheimers Res Ther (2015) 0.87
Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association. Hypertension (2016) 0.87
White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease. EBioMedicine (2015) 0.86
The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment. Alzheimers Dement (2015) 0.85
Genetic architecture of white matter hyperintensities differs in hypertensive and nonhypertensive ischemic stroke. Stroke (2014) 0.84
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network. Ann Neurol (2016) 0.82
Neuropathologic correlates of regional brain volumes in a community cohort of older adults. Neurobiol Aging (2015) 0.82
Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease. J Alzheimers Dis (2015) 0.81
APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role? Alzheimers Dement (2014) 0.81
White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters. Neurobiol Aging (2015) 0.81
Cerebral small vessel disease and Alzheimer's disease. Clin Interv Aging (2015) 0.80
Longitudinal patterns of leukoaraiosis and brain atrophy in symptomatic small vessel disease. Brain (2016) 0.80
Strategic lesions in the anterior thalamic radiation and apathy in early Alzheimer's disease. PLoS One (2015) 0.79
White matter and memory in healthy adults: Coupled changes over two years. Neuroimage (2015) 0.79
White matter hyperintensities and imaging patterns of brain ageing in the general population. Brain (2016) 0.79
Dynamic Progression of White Matter Hyperintensities in Alzheimer's Disease and Normal Aging: Results from the Sunnybrook Dementia Study. Front Aging Neurosci (2016) 0.79
Comparison of cerebral blood flow and structural penumbras in relation to white matter hyperintensities: A multi-modal magnetic resonance imaging study. J Cereb Blood Flow Metab (2016) 0.79
Binswanger's disease: toward a diagnosis agreement and therapeutic approach. Expert Rev Neurother (2014) 0.78
Differential aging of cerebral white matter in middle-aged and older adults: A seven-year follow-up. Neuroimage (2015) 0.78
Determinants of white matter hyperintensity burden differ at the extremes of ages of ischemic stroke onset. J Stroke Cerebrovasc Dis (2014) 0.77
Peripheral (deep) but not periventricular MRI white matter hyperintensities are increased in clinical vascular dementia compared to Alzheimer's disease. Brain Behav (2016) 0.77
The role of cerebrovascular disease when there is concomitant Alzheimer disease. Biochim Biophys Acta (2015) 0.77
Longitudinal relaxographic imaging of white matter hyperintensities in the elderly. Fluids Barriers CNS (2014) 0.77
Differential Regional Distribution of Juxtacortical White Matter Signal Abnormalities in Aging and Alzheimer's Disease. J Alzheimers Dis (2017) 0.76
Regional staging of white matter signal abnormalities in aging and Alzheimer's disease. Neuroimage Clin (2017) 0.76
Cortical tau load is associated with white matter hyperintensities. Acta Neuropathol Commun (2015) 0.75
Evoked Potentials and Memory/Cognition Tests Validate Brain Atrophy as Measured by 3T MRI (NeuroQuant) in Cognitively Impaired Patients. PLoS One (2015) 0.75
An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease. Alzheimers Dement (2016) 0.75
Homocysteine Level Is Associated with White Matter Hyperintensity Locations in Patients with Acute Ischemic Stroke. PLoS One (2015) 0.75
DNA damage in the oligodendrocyte lineage and its role in brain aging. Mech Ageing Dev (2016) 0.75
Imaging markers of cerebrovascular pathologies: Pathophysiology, clinical presentation, and risk factors. Alzheimers Dement (Amst) (2016) 0.75
A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers. J Alzheimers Dis (2017) 0.75
Blood Pressure Control in Aging Predicts Cerebral Atrophy Related to Small-Vessel White Matter Lesions. Front Aging Neurosci (2017) 0.75
A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting. Neurol Sci (2017) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (2010) 7.93
Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging (1995) 6.86
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol (2011) 6.00
Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology (1992) 5.95
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci (2011) 5.64
The Mini-Mental State Examination. Arch Gen Psychiatry (1983) 5.20
Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr (1997) 4.87
White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke (2006) 3.27
Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke (2004) 3.26
Alzheimer disease as a vascular disorder: nosological evidence. Stroke (2002) 3.17
Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Neurology (2005) 2.76
White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry (2002) 2.72
Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol (2008) 2.71
Chronic traumatic encephalopathy: a potential late effect of sport-related concussive and subconcussive head trauma. Clin Sports Med (2011) 2.60
The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann Intern Med (1987) 2.58
Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke (2008) 2.48
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry (2010) 2.44
Neuropathologic correlates of white matter hyperintensities. Neurology (2008) 2.29
Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment. Stroke (2008) 2.21
Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology (2008) 2.00
Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch Neurol (2010) 1.94
Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry (2002) 1.88
The Oregon brain aging study: neuropathology accompanying healthy aging in the oldest old. Neurology (2000) 1.85
Trajectory of white matter hyperintensity burden preceding mild cognitive impairment. Neurology (2012) 1.66
Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain (2012) 1.47
Cognitive impairment risk: white matter hyperintensity progression matters. Neurology (2009) 1.46
Progression of white matter hyperintensities in elderly individuals over 3 years. Neurology (2007) 1.44
2001-2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease? Cerebrovasc Dis (2011) 1.40
Brain volume preserved in healthy elderly through the eleventh decade. Neurology (1998) 1.36
Natural history of cognitive decline in the old old. Neurology (2003) 1.31
Vascular risk factors: imaging and neuropathologic correlates. J Alzheimers Dis (2010) 1.22
Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well. J Neurol Sci (2007) 1.15
Oligemic hypoperfusion differentially affects tau and amyloid-{beta}. Am J Pathol (2010) 1.13
Cerebrovascular hypoperfusion induces spatial memory impairment, synaptic changes, and amyloid-β oligomerization in rats. J Alzheimers Dis (2010) 0.90
Differential changes in phosphorylation of tau at PHF-1 and 12E8 epitopes during brain ischemia and reperfusion in gerbils. Neurochem Res (2006) 0.87
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med (2005) 12.04
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol (2004) 4.66
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging (2009) 4.36
Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology (2004) 3.94
Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol (2003) 3.75
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol (2007) 3.55
Intelligent Systems For Assessing Aging Changes: home-based, unobtrusive, and continuous assessment of aging. J Gerontol B Psychol Sci Soc Sci (2011) 2.71
Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol (2002) 2.70
The trajectory of gait speed preceding mild cognitive impairment. Arch Neurol (2010) 2.66
Status of computerized cognitive testing in aging: a systematic review. Alzheimers Dement (2008) 2.52
Dance and reducing television viewing to prevent weight gain in African-American girls: the Stanford GEMS pilot study. Ethn Dis (2003) 2.41
Depressive symptoms and cognitive decline in late life: a prospective epidemiological study. Arch Gen Psychiatry (2006) 2.41
Unobtrusive and ubiquitous in-home monitoring: a methodology for continuous assessment of gait velocity in elders. IEEE Trans Biomed Eng (2009) 2.30
The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol (2010) 2.19
Utilization of upper endoscopy for surveillance of gastric ulcers in the United States. Am J Gastroenterol (2008) 2.14
Exercise level and cognitive decline: the MoVIES project. Alzheimer Dis Assoc Disord (2004) 2.13
Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization. Clin Infect Dis (2006) 1.95
Complications of pediatric EGD: a 4-year experience in PEDS-CORI. Gastrointest Endosc (2007) 1.89
Dementia assessment in primary care: results from a study in three managed care systems. J Gerontol A Biol Sci Med Sci (2004) 1.86
Safety and acceptability of the research lumbar puncture. Alzheimer Dis Assoc Disord (2005) 1.82
Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease. Ann Neurol (2002) 1.79
Ecology of the aging human brain. Arch Neurol (2011) 1.78
Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry. Gastroenterology (2013) 1.77
Imaging markers for Alzheimer disease: which vs how. Neurology (2013) 1.76
Different patterns of cerebral injury in dementia with or without diabetes. Arch Neurol (2009) 1.76
Hemoglobin levels and Alzheimer disease: an epidemiologic study in India. Am J Geriatr Psychiatry (2004) 1.69
Trajectory of white matter hyperintensity burden preceding mild cognitive impairment. Neurology (2012) 1.66
Assessment of the quality of colonoscopy reports: results from a multicenter consortium. Gastrointest Endosc (2009) 1.64
Detection and management of cognitive impairment in primary care: The Steel Valley Seniors Survey. J Am Geriatr Soc (2004) 1.59
A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep (2003) 1.58
Rates and predictors of mortality in an aging, rural, community-based cohort: the role of depression. Arch Gen Psychiatry (2002) 1.57
Dysregulated phosphorylation of Ca(2+) /calmodulin-dependent protein kinase II-α in the hippocampus of subjects with mild cognitive impairment and Alzheimer's disease. J Neurochem (2011) 1.56
Age at onset of Parkinson disease and apolipoprotein E genotypes. Am J Med Genet (2002) 1.56
Alzheimer disease and mortality: a 15-year epidemiological study. Arch Neurol (2005) 1.55
Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. J Alzheimers Dis (2005) 1.55
Predictors of nursing facility admission: a 12-year epidemiological study in the United States. J Am Geriatr Soc (2004) 1.52
Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol (2008) 1.52
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimers Dement (2009) 1.49
Cognitive impairment risk: white matter hyperintensity progression matters. Neurology (2009) 1.46
Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers. J Consult Clin Psychol (2004) 1.41
Depression after stroke: a prospective epidemiological study. J Am Geriatr Soc (2004) 1.40
CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells. Blood (2006) 1.39
New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN. Neurology (2012) 1.35
An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consortium. Gastrointest Endosc (2008) 1.32
Federally qualified health centers and private practice performance on ambulatory care measures. Am J Prev Med (2012) 1.32
Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 2. Alzheimers Dement (2011) 1.29
Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database. Am J Gastroenterol (2007) 1.22
Physical activity and the risk of dementia in oldest old. J Aging Health (2007) 1.22
Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment. J Mol Neurosci (2003) 1.22
Behavioral change in persons with dementia: relationships with mental and physical health of caregivers. J Gerontol B Psychol Sci Soc Sci (2002) 1.19
Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol (2014) 1.18
Age- and sex-specific yield of Barrett's esophagus by endoscopy indication. Gastrointest Endosc (2009) 1.17
One walk a year to 1000 within a year: continuous in-home unobtrusive gait assessment of older adults. Gait Posture (2011) 1.16
Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging. PLoS One (2011) 1.12
The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcome. Ann Surg (2010) 1.12
Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study. J Am Geriatr Soc (2002) 1.11
Comparison of morning versus afternoon cecal intubation rates. BMC Gastroenterol (2007) 1.11
The spectrum of central nervous system infections in an adult referral hospital in Hanoi, Vietnam. PLoS One (2012) 1.09
Cognitive decline and mortality in a community-based cohort: the Monongahela Valley Independent Elders Survey. J Am Geriatr Soc (2008) 1.09
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol (2014) 1.08
Neuropathologic basis of age-associated brain atrophy. JAMA Neurol (2013) 1.05
apoE isoforms and measures of anxiety in probable AD patients and Apoe-/- mice. Neurobiol Aging (2005) 1.03
A closer look at same-day bidirectional endoscopy. Gastrointest Endosc (2008) 1.02
Assessment of cognition in mild cognitive impairment: a comparative study. Alzheimers Dement (2011) 1.00
Computer-related self-efficacy and anxiety in older adults with and without mild cognitive impairment. Alzheimers Dement (2012) 0.99
Unobtrusive assessment of walking speed in the home using inexpensive PIR sensors. Conf Proc IEEE Eng Med Biol Soc (2009) 0.99
Executive function predicts risk of falls in older adults without balance impairment. BMC Geriatr (2011) 0.98
Supervised and Unsupervised Feature Selection for Inferring Social Nature of Telephone Conversations from Their Content. Proc IEEE Workshop Autom Speech Recognit Underst (2003) 0.98
Correlations of Perceived Deficits Questionnaire of Multiple Sclerosis Quality of Life Inventory with Beck Depression Inventory and neuropsychological tests. J Rehabil Res Dev (2006) 0.98
F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease. J Mol Neurosci (2007) 0.97
A biomechanical study comparing a raft of 3.5 mm cortical screws with 6.5 mm cancellous screws in depressed tibial plateau fractures. Knee (2006) 0.97
Validity of the clinical dementia rating scale for the detection and staging of dementia in Brazilian patients. Alzheimer Dis Assoc Disord (2007) 0.96
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A (2012) 0.95
Measuring motor speed through typing: a surrogate for the finger tapping test. Behav Res Methods (2011) 0.95
Assessment of cognition in early dementia. Alzheimers Dement (2011) 0.94
Role of biomarkers in studies of presymptomatic Alzheimer's disease. Alzheimers Dement (2005) 0.94
Spoken Language Derived Measures for Detecting Mild Cognitive Impairment. IEEE Trans Audio Speech Lang Process (2011) 0.93
Metabolic syndrome and cognitive decline among the oldest old in Okinawa: in search of a mechanism. The KOCOA Project. J Gerontol A Biol Sci Med Sci (2011) 0.93
Gambling participation and social support among older adults: a longitudinal community study. J Gambl Stud (2004) 0.93
Deactivation of Akt by a small molecule inhibitor targeting pleckstrin homology domain and facilitating Akt ubiquitination. Proc Natl Acad Sci U S A (2011) 0.93
Predictors of normal and successful aging among urban-dwelling elderly Brazilians. J Gerontol B Psychol Sci Soc Sci (2009) 0.92
Pilot study to show the feasibility of a multicenter trial of home-based assessment of people over 75 years old. Alzheimer Dis Assoc Disord (2010) 0.92
Scenery Picture Memory Test: a new type of quick and effective screening test to detect early stage Alzheimer's disease patients. Geriatr Gerontol Int (2010) 0.92
Postoperative infections due to bladder catheters after anterior colporrhaphy: a prospective, randomized three-arm study. Int Urogynecol J (2010) 0.92
A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease. J Alzheimers Dis (2014) 0.91